|
|
|
|
|
|
|
Vistagen Therap. Com (VTGN)
|
|
0.93 -0.15 (-13.89%)
|
04-20 16:00
|
|
Open:
|
0.95
|
Pre. Close:
|
1.08
|
|
High:
|
0.98
|
Low:
|
0.88
|
|
Volume:
|
1,224,044
|
Market Cap:
|
21M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
0.981 - 0.988
|
0.988 - 0.994
|
|
Low:
|
0.863 - 0.872
|
0.872 - 0.879
|
|
Close:
|
0.918 - 0.93
|
0.93 - 0.939
|
|
|
|
Technical analysis (as of: 2018-04-20 4:34:43 PM)
|
|
Overall:
|
|
|
Stoxline posted a STRONG SELL today, same as yesterday. This stock still seems to be very strong for short side. So you may continue to hold the short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.
|
|
Target:
|
Six months: 1.39 One year: 1.62
|
|
Support:
|
Support1: 0.86 Support2: 0.72
|
|
Resistance:
|
Resistance1:
1.19 Resistance2: 1.39
|
|
Pivot:
|
1.05
|
|
Moving Averages:
|
MA(5): 1.10  MA(20): 1.03
MA(100): 1.18  MA(250): 1.46
|
|
MACD:
|
MACD(12,26):
-0.03 Signal(12,26,9): -0.03
|
|
%K %D:
|
%K(14,3): 55.21 %D(3): 75.59
|
|
RSI:
|
RSI(14): 36.17
|
|
52-Week:
|
High: 2.65
Low: 0.69 Change(%): -51.8
|
|
Average Vol(K):
|
3-Month: 53840
10-Days 31851
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.VTGN has closed above bottom band by 15.5%. Bollinger Bands are 41% narrower than normal. The narrow width of the bands suggests low volatility as compared to VTGN's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
2018-04-20T12:55:22-04:00
Midday Gainers / Losers (04/20/2018)
2018-04-20T11:39:29-04:00
Vistagen down 11% on mixed esketamine data
2018-04-20T09:17:06-04:00
Premarket Losers as of 9:05 am (04/20/2018)
2018-04-06T11:18:40-04:00
Your Daily Pharma Scoop: Conatus Setback, Applied DNA Signs Agreement, Evolus Announces Results From Late-Stage Study
2018-04-05T08:45:23-04:00
VistaGen Therapeutics initiates Phase 2 study of AV-101 for MDD
2018-03-21T13:49:04-04:00
Vistagen - Nanocap CNS Drug Chasing Ketamine Fame
2018-03-16T10:25:46-04:00
Key events next week - healthcare
2018-03-09T11:51:14-05:00
Your Daily Pharma Scoop: Progenics Rallies, Merck To Partner With Eisai, Teva Upsizes Debt Offering
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
